Runx3-mediated transcriptional program in cytotoxic lymphocytes

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Lotem, Joseph ^a   Levanon, Ditsa ^a   Negreanu, Varda ^a   Leshkowitz, Dena ^a   Friedlander, Gilgi ^a   Groner, Yoram ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 2; TRANSCRIPTION FACTOR RUNX3; TRANSCRIPTION FACTOR T BET; TRANSCRIPTOME;

ARTICLE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL MIGRATION; CELL PROLIFERATION; CELL TYPE; CYTOKINE PRODUCTION; CYTOTOXIC LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; ENHANCER REGION; GENE CONTROL; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NATURAL KILLER T CELL; PROTEIN MOTIF; TH1 CELL; WILD TYPE;

ANIMALS; CORE BINDING FACTOR ALPHA 3 SUBUNIT; ENHANCER ELEMENTS, GENETIC; G0 PHASE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HISTONES; INTERLEUKIN-2; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; NUCLEOTIDE MOTIFS; POSITION-SPECIFIC SCORING MATRICES; PROTEIN BINDING; T-LYMPHOCYTES, CYTOTOXIC; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION, GENETIC;

EID: 84893398719     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080467     Document Type: Article

References (78)

1. Levanon D, Groner Y (2004) Structure and regulated expression of mammalian RUNX genes. Oncogene 23: 4211-4219. doi:10.1038/sj.onc.1207670. PubMed: 15156175. (Pubitemid 38758586)
2. de Bruijn MF, Speck NA (2004) Core-binding factors in hematopoiesis and immune function. Oncogene 23: 4238-4248. doi:10.1038/sj.onc.1207763. PubMed: 15156179.
3. Stein GS, Lian JB, van Wijnen AJ, Stein JL, Montecino M et al. (2004) Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression. Oncogene 23: 4315-4329. doi:10.1038/sj.onc. 1207676. PubMed: 15156188. (Pubitemid 38758597)
4. + T cells. Nat Rev Immunol 11: 645-657. doi:10.1038/nri3044. PubMed: 21869816.
5. Taniuchi I, Osato M, Egawa T, Sunshine MJ, Bae SC et al. (2002) Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell 111: 621-633. doi:10.1016/S0092-8674(02)01111-X. PubMed: 12464175. (Pubitemid 35441245)
6. Woolf E, Xiao C, Fainaru O, Lotem J, Rosen D et al. (2003) Runx3 and Runx1 are required for CD8 T cell development during thymopoiesis. Proc Natl Acad Sci U S A 100: 7731-7736. doi:10.1073/pnas.1232420100. PubMed: 12796513. (Pubitemid 36760038)
7. Cruz-Guilloty F, Pipkin ME, Djuretic IM, Levanon D, Lotem J et al. (2009) Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs. J Exp Med 206: 51-59. doi:10.1084/jem.20081242. PubMed: 19139168.
8. Glimcher LH, Townsend MJ, Sullivan BM, Lord GM (2004) Recent developments in the transcriptional regulation of cytolytic effector cells. Nat Rev Immunol 4: 900-911. doi:10.1038/nri1490. PubMed: 15516969. (Pubitemid 39490765)
9. Hesslein DG, Lanier LL (2011) Transcriptional control of natural killer cell development and function. Adv Immunol 109: 45-85. doi:10.1016/B978-0-12- 387664-5.00002-9. PubMed: 21569912.
10. Levanon D, Brenner O, Negreanu V, Bettoun D, Woolf E et al. (2001) Spatial and temporal expression pattern of Runx3 (Aml2) and Runx1 (Aml1) indicates non-redundant functions during mouse embryogenesis. Mech Dev 109: 413-417. doi:10.1016/S0925-4773(01)00537-8. PubMed: 11731260. (Pubitemid 33112059)
11. Pekowska A, Benoukraf T, Zacarias-Cabeza J, Belhocine M, Koch F et al. (2011) H3K4 tri-methylation provides an epigenetic signature of active enhancers. EMBO J 30: 4198-4210. doi:10.1038/emboj.2011.295. PubMed: 21847099.
12. Moretta L, Biassoni R, Bottino C, Mingari MC, Moretta A (2001) Immunobiology of human NK cells. Transplant Proc 33: 60-61. doi:10.1016/S0041- 1345(00)02790-1. PubMed: 11266706. (Pubitemid 32237262)
13. Björkström NK, Béziat V, Cichocki F, Liu LL, Levine J et al. (2012) CD8 T cells express randomly selected KIRs with distinct specificities compared with NK cells. Blood 120: 3455-3465. doi:10.1182/blood- 2012-03-416867. PubMed: 22968455.
14. Ben-Ami O, Friedman D, Leshkowitz D, Goldenberg D, Orlovsky K et al. (2013) Addiction of t(8;21) and inv(16) acute myeloid leukemia to native RUNX1. Cell Rep 4: 1131-1143. doi:10.1016/j.celrep.2013.08.020. PubMed: 24055056.
15. Pencovich N, Jaschek R, Tanay A, Groner Y (2011) Dynamic combinatorial interactions of RUNX1 and cooperating partners regulates megakaryocytic differentiation in cell line models. Blood 117: e1-14. doi:10.1182/blood-2010- 10-311217. PubMed: 20959602.
16. Farnham PJ (2009) Insights from genomic profiling of transcription factors. Nat Rev Genet 10: 605-616. doi:10.1038/nrg2636. PubMed: 19668247.
17. Ito Y (2008) RUNX genes in development and cancer: regulation of viral gene expression and the discovery of RUNX family genes. Adv Cancer Res 99: 33-76. doi:10.1016/S0065-230X(07)99002-8. PubMed: 18037406.
18. Machanick P, Bailey TL (2011) MEME-ChIP: motif analysis of large DNA datasets. Bioinformatics 27: 1696-1697. doi:10.1093/bioinformatics/btr189. PubMed: 21486936.
19. McLean CY, Bristor D, Hiller M, Clarke SL, Schaar BT et al. (2010) GREAT improves functional interpretation of cis-regulatory regions. Nat Biotechnol 28: 495-501. doi:10.1038/nbt.1630. PubMed: 20436461.
20. Setoguchi R, Tachibana M, Naoe Y, Muroi S, Akiyama K et al. (2008) Repression of the transcription factor Th-POK by Runx complexes in cytotoxic T cell development. Science 319: 822-825. doi:10.1126/science.1151844. PubMed: 18258917. (Pubitemid 351225874)
21. Grueter B, Petter M, Egawa T, Laule-Kilian K, Aldrian CJ et al. (2005) Runx3 regulates integrin alpha E/CD103 and CD4 expression during development of CD4-/CD8+ T cells. J Immunol 175: 1694-1705. PubMed: 16034110. (Pubitemid 41023073)
22. Yarmus M, Woolf E, Bernstein Y, Fainaru O, Negreanu V et al. (2006) Groucho/transducin-like Enhancer-of-split (TLE)-dependent and - independent transcriptional regulation by Runx3. Proc Natl Acad Sci U S A 103: 7384-7389. doi:10.1073/pnas.0602470103. PubMed: 16651517. (Pubitemid 43727842)
23. Smid M, Dorssers LC, Jenster G (2003) Venn Mapping: clustering of heterologous microarray data based on the number of co-occurring differentially expressed genes. Bioinformatics 19: 2065-2071. doi:10.1093/bioinformatics/ btg282. PubMed: 14594711. (Pubitemid 37408157)
24. Vahedi G, Takahashi H, Nakayamada S, Sun HW, Sartorelli V et al. (2012) STATs Shape the Active Enhancer Landscape of T Cell Populations. Cell 151: 981-993. doi:10.1016/j.cell.2012.09.044. PubMed: 23178119.
25. Nakayamada S, Kanno Y, Takahashi H, Jankovic D, Lu KT et al. (2011) Early Th1 cell differentiation is marked by a Tfh cell-like transition. Immunity 35: 919-931. doi:10.1016/j.immuni.2011.11.012. PubMed: 22195747.
26. Djuretic IM, Levanon D, Negreanu V, Groner Y, Rao A et al. (2007) Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells. Nat Immunol 8: 145-153. doi:10.1038/ni1424. PubMed: 17195845. (Pubitemid 46152645)
27. Naoe Y, Setoguchi R, Akiyama K, Muroi S, Kuroda M et al. (2007) Repression of interleukin-4 in T helper type 1 cells by Runx/Cbf beta binding to the Il4 silencer. J Exp Med 204: 1749-1755. doi:10.1084/jem.20062456. PubMed: 17646405. (Pubitemid 47236313)
28. Gordon SM, Chaix J, Rupp LJ, Wu J, Madera S et al. (2012) The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation. Immunity 36: 55-67. doi:10.1016/j.immuni.2011.11.016. PubMed: 22261438.
29. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL et al. (2005) Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-15550. doi:10.1073/pnas.0506580102. PubMed: 16199517. (Pubitemid 41528093)
30. Labalette C, Nouët Y, Sobczak-Thepot J, Armengol C, Levillayer F et al. (2008) The LIM-only protein FHL2 regulates cyclin D1 expression and cell proliferation. J Biol Chem 283: 15201-15208. doi:10.1074/jbc.M800708200. PubMed: 18378678.
31. Hendrix A, Maynard D, Pauwels P, Braems G, Denys H et al. (2010) Effect of the secretory small GTPase Rab27B on breast cancer growth, invasion, and metastasis. J Natl Cancer Inst 102: 866-880. doi:10.1093/jnci/djq153. PubMed: 20484105.
32. Murray CM, Hutchinson R, Bantick JR, Belfield GP, Benjamin AD et al. (2005) Monocarboxylate transporter MCT1 is a target for immunosuppression. Nat Chem Biol 1: 371-376. doi:10.1038/nchembio744. PubMed: 16370372.
33. Melero I, Murillo O, Dubrot J, Hervás-Stubbs S, Perez-Gracia JL (2008) Multi-layered action mechanisms of CD137 (4-1BB)-targeted immunotherapies. Trends Pharmacol Sci 29: 383-390. doi:10.1016/j.tips.2008.05. 005. PubMed: 18599129.
34. Kutlesa S, Wessels JT, Speiser A, Steiert I, Müller CA et al. (2002) E-cadherin-mediated interactions of thymic epithelial cells with CD103+ thymocytes lead to enhanced thymocyte cell proliferation. J Cell Sci 115: 4505-4515. doi:10.1242/jcs.00142. PubMed: 12414996. (Pubitemid 36004411)
35. Bluman EM, Schnier GS, Avalos BR, Strout MP, Sultan H et al. (1996) The c-kit ligand potentiates the allogeneic mixed lymphocyte reaction. Blood 88: 3887-3893. PubMed: 8916954. (Pubitemid 26383112)
36. Hurlin PJ, Dezfouli S (2004) Functions of myc:max in the control of cell proliferation and tumorigenesis. Int Rev Cytol 238: 183-226. doi:10.1016/S0074-7696(04)38004-6. PubMed: 15364199. (Pubitemid 39201316)
37. Alcázar I, Marqués M, Kumar A, Hirsch E, Wymann M et al. (2007) Phosphoinositide 3-kinase gamma participates in T cell receptor-induced T cell activation. J Exp Med 204: 2977-2987. doi:10.1084/jem.20070366. PubMed: 17998387. (Pubitemid 350179565)
38. Miaczynska M, Christoforidis S, Giner A, Shevchenko A, Uttenweiler-Joseph S et al. (2004) APPL proteins link Rab5 to nuclear signal transduction via an endosomal compartment. Cell 116: 445-456. doi:10.1016/S0092-8674(04)00117-5. PubMed: 15016378. (Pubitemid 38366320)
39. Greig KT, Carotta S, Nutt SL (2008) Critical roles for c-Myb in hematopoietic progenitor cells. Semin Immunol 20: 247-256. doi:10.1016/j.smim. 2008.05.003. PubMed: 18585056.
40. Liu L, Yu XZ, Li TS, Song LX, Chen PL et al. (2004) A novel protein tyrosine kinase NOK that shares homology with platelet- derived growth factor/fibroblast growth factor receptors induces tumorigenesis and metastasis in nude mice. Cancer Res 64: 3491-3499. doi:10.1158/0008-5472.CAN-03-2106. PubMed: 15150103. (Pubitemid 38657923)
41. Shen R, Ouyang YB, Qu CK, Alonso A, Sperzel L et al. (2002) Grap negatively regulates T-cell receptor-elicited lymphocyte proliferation and interleukin-2 induction. Mol Cell Biol 22: 3230-3236. doi:10.1128/MCB.22.10. 3230-3236.2002. PubMed: 11971956. (Pubitemid 34453965)
42. Brady G, Farrell PJ (2009) RUNX3-mediated repression of RUNX1 in B cells. J Cell Physiol 221: 283-287. doi:10.1002/jcp.21880. PubMed: 19603429.
43. Modiano JF, Johnson LD, Bellgrau D (2008) Negative regulators in homeostasis of naïve peripheral T cells. Immunol Res 41: 137-153. doi:10.1007/s12026-008-8017-1. PubMed: 18415030.
44. Tarrant JM, Groom J, Metcalf D, Li R, Borobokas B et al. (2002) The absence of Tssc6, a member of the tetraspanin superfamily, does not affect lymphoid development but enhances in vitro T-cell proliferative responses. Mol Cell Biol 22: 5006-5018. doi:10.1128/MCB.22.14.5006-5018.2002. PubMed: 12077330. (Pubitemid 34700693)
45. Dyson JM, Fedele CG, Davies EM, Becanovic J, Mitchell CA (2012) Phosphoinositide phosphatases: just as important as the kinases. Subcell Biochem 58: 215-279. doi:10.1007/978-94-007-3012-0-7. PubMed: 22403078.
46. Rothenberg EV, Zhang J, Li L (2010) Multilayered specification of the T-cell lineage fate. Immunol Rev 238: 150-168. doi:10.1111/j.1600-065X.2010. 00964.x. PubMed: 20969591.
47. Schmitt TM, Ciofani M, Petrie HT, Zúñiga-Pflücker JC (2004) Maintenance of T cell specification and differentiation requires recurrent notch receptor-ligand interactions. J Exp Med 200: 469-479. doi:10.1084/jem.20040394. PubMed: 15314075. (Pubitemid 39121904)
48. Collins A, Littman DR, Taniuchi I (2009) RUNX proteins in transcription factor networks that regulate T-cell lineage choice. Nat Rev Immunol 9: 106-115. doi:10.1038/nri2489. PubMed: 19165227.
49. Lai CB, Mager DL (2012) Role of runt-related transcription factor 3 (RUNX3) in transcription regulation of natural cytotoxicity receptor 1 (NCR1/NKp46), an activating natural killer (NK) cell receptor. J Biol Chem 287: 7324-7334. doi:10.1074/jbc.M111.306936. PubMed: 22253448.
50. Presnell SR, Zhang L, Chlebowy CN, Al-Attar A, Lutz CT (2012) Differential transcription factor use by the KIR2DL4 promoter under constitutive and IL-2/15-treated conditions. J Immunol 188: 4394-4404. doi:10.4049/jimmunol. 1103352. PubMed: 22467658.
51. Bezman NA, Kim CC, Sun JC, Min-Oo G, Hendricks DW et al. (2012) Molecular definition of the identity and activation of natural killer cells. Nat Immunol 13: 1000-1009. doi:10.1038/ni.2395. PubMed: 22902830.
52. Tijssen MR, Cvejic A, Joshi A, Hannah RL, Ferreira R et al. (2011) Genome-wide analysis of simultaneous GATA1/2, RUNX1, FLI1, and SCL binding in megakaryocytes identifies hematopoietic regulators. Dev Cell 20: 597-609. doi:10.1016/j.devcel.2011.04.008. PubMed: 21571218.
53. Little GH, Noushmehr H, Baniwal SK, Berman BP, Coetzee GA et al. (2012) Genome-wide Runx2 occupancy in prostate cancer cells suggests a role in regulating secretion. Nucleic Acids Res 40: 3538-3547. doi:10.1093/nar/gkr1219. PubMed: 22187159.
54. Pencovich N, Jaschek R, Dicken J, Amit A, Lotem J et al. (2013) Cell-autonomous function of runx1 transcriptionally regulates mouse megakaryocytic maturation. PLOS ONE 8: e64248. doi:10.1371/journal.pone.0064248. PubMed: 23717578.
55. Wotton D, Ghysdael J, Wang S, Speck NA, Owen MJ (1994) Cooperative binding of Ets-1 and core binding factor to DNA. Mol Cell Biol 14: 840-850. PubMed: 8264651.
56. Wai PY, Mi Z, Gao C, Guo H, Marroquin C et al. (2006) Ets-1 and runx2 regulate transcription of a metastatic gene, osteopontin, in murine colorectal cancer cells. J Biol Chem 281: 18973-18982. doi:10.1074/jbc.M511962200. PubMed: 16670084. (Pubitemid 44035400)
57. Arman M, Aguilera-Montilla N, Mas V, Puig-Kröger A, Pignatelli M et al. (2009) The human CD6 gene is transcriptionally regulated by RUNX and Ets transcription factors in T cells. Mol Immunol 46: 2226-2235. doi:10.1016/j.molimm.2009.04.018. PubMed: 19446338.
58. Shen Y, Yue F, McCleary DF, Ye Z, Edsall L et al. (2012) A map of the cis-regulatory sequences in the mouse genome. Nature 488: 116-120. doi:10.1038/nature11243. PubMed: 22763441.
59. Clements JL, John SA, Garrett-Sinha LA (2006) Impaired generation of CD8+ thymocytes in Ets-1-deficient mice. J Immunol 177: 905-912. PubMed: 16818745.
60. Zamisch M, Tian L, Grenningloh R, Xiong Y, Wildt KF et al. (2009) The transcription factor Ets1 is important for CD4 repression and Runx3 up-regulation during CD8 T cell differentiation in the thymus. J Exp Med 206: 2685-2699. doi:10.1084/jem.20092024. PubMed: 19917777.
61. Ramirez K, Chandler KJ, Spaulding C, Zandi S, Sigvardsson M et al. (2012) Gene deregulation and chronic activation in natural killer cells deficient in the transcription factor ETS1. Immunity 36: 921-932. doi:10.1016/j.immuni.2012. 04.006. PubMed: 22608498.
62. Kohu K, Ohmori H, Wong WF, Onda D, Wakoh T et al. (2009) The Runx3 transcription factor augments Th1 and down-modulates Th2 phenotypes by interacting with and attenuating GATA3. J Immunol 183: 7817-7824. doi:10.4049/jimmunol.0802527. PubMed: 19933870.
63. Xiong Y, Castro E, Yagi R, Zhu J, Lesourne R et al. (2013) Thpok-independent repression of Runx3 by Gata3 during CD4(+) T-cell differentiation in the thymus. Eur J Immunol 43(4):918-28.
64. Spender LC, Whiteman HJ, Karstegl CE, Farrell PJ (2005) Transcriptional cross-regulation of RUNX1 by RUNX3 in human B cells. Oncogene 24: 1873-1881. doi:10.1038/sj.onc.1208404. PubMed: 15688019. (Pubitemid 40462789)
65. Lichtinger M, Ingram R, Hannah R, Müller D, Clarke D et al. (2012) RUNX1 reshapes the epigenetic landscape at the onset of haematopoiesis. EMBO J 31: 4318-4333. doi:10.1038/emboj.2012.275. PubMed: 23064151.
66. Hess J, Porte D, Munz C, Angel P (2001) AP-1 and Cbfa/runt physically interact and regulate parathyroid hormone-dependent MMP13 expression in osteoblasts through a new osteoblast-specific element 2/AP-1 composite element. J Biol Chem 276: 20029-20038. doi:10.1074/jbc.M010601200. PubMed: 11274169.
67. Rincón M, Flavell RA (1994) AP-1 transcriptional activity requires both T-cell receptor-mediated and co-stimulatory signals in primary T lymphocytes. EMBO J 13: 4370-4381. PubMed: 7925281. (Pubitemid 24295209)
68. Marusina AI, Burgess SJ, Pathmanathan I, Borrego F, Coligan JE (2008) Regulation of human DAP10 gene expression in NK and T cells by Ap-1 transcription factors. J Immunol 180: 409-417. PubMed: 18097042.
69. Groh V, Rhinehart R, Randolph-Habecker J, Topp MS, Riddell SR et al. (2001) Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol 2: 255-260. doi:10.1038/85321. PubMed: 11224526. (Pubitemid 33706003)
70. Morlon A, Sassone-Corsi P (2003) The LIM-only protein FHL2 is a serum-inducible transcriptional coactivator of AP-1. Proc Natl Acad Sci U S A 100: 3977-3982. doi:10.1073/pnas.0735923100. PubMed: 12644711. (Pubitemid 36418142)
71. Günther T, Poli C, Müller JM, Catala-Lehnen P, Schinke T et al. (2005) Fhl2 deficiency results in osteopenia due to decreased activity of osteoblasts. EMBO J 24: 3049-3056. doi:10.1038/sj.emboj.7600773. PubMed: 16079911. (Pubitemid 41486341)
72. Bai S, Zha J, Zhao H, Ross FP, Teitelbaum SL (2008) Tumor necrosis factor receptor-associated factor 6 is an intranuclear transcriptional coactivator in osteoclasts. J Biol Chem 283: 30861-30867. doi:10.1074/jbc.M802525200. PubMed: 18768464.
73. So T, Croft M (2013) Regulation of PI-3-Kinase and Akt Signaling in T Lymphocytes and Other Cells by TNFR Family Molecules. Front Immunol 4: 139. PubMed: 23760533.
74. Wilcox RA, Tamada K, Strome SE, Chen L (2002) Signaling through NK cell-associated CD137 promotes both helper function for CD8+ cytolytic T cells and responsiveness to IL-2 but not cytolytic activity. J Immunol 169: 4230-4236. PubMed: 12370353. (Pubitemid 35178194)
75. Benson DM Jr, Yu J, Becknell B, Wei M, Freud AG et al. (2009) Stem cell factor and interleukin-2/15 combine to enhance MAPK-mediated proliferation of human natural killer cells. Blood 113: 2706-2714. doi: 10.1182/blood-2008-05- 159285. PubMed: 19060242.
76. Yáñez-Mó M, Barreiro O, Gordon-Alonso M, Sala-Valdés M, Sánchez-Madrid F (2009) Tetraspanin-enriched microdomains: a functional unit in cell plasma membranes. Trends Cell Biol 19: 434-446. doi:10.1016/j.tcb.2009.06.004. PubMed: 19709882.
77. Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS et al. (2008) Model-based analysis of ChIP-Seq (MACS). Genome Biol 9: R137. doi: 10.1186/gb-2008-9-9-r137. PubMed: 18798982.
78. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264. doi:10.1093/biostatistics/4. 2.249. PubMed: 12925520.